Data gathered: October 13
Alternative Data for Arcutis Biotherapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 6 | Sign up | Sign up | Sign up |
| Sentiment | 97 | Sign up | Sign up | Sign up |
| Webpage traffic | 14,000 | Sign up | Sign up | Sign up |
| Employee Rating | 88 | Sign up | Sign up | Sign up |
| Google Trends | 10 | Sign up | Sign up | Sign up |
| Patents | 36 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 81 | Sign up | Sign up | Sign up |
| Facebook Followers | 2,514 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 4 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,078 | Sign up | Sign up | Sign up |
| Twitter Followers | 556 | Sign up | Sign up | Sign up |
| Twitter Mentions | 11 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 48 | Sign up | Sign up | Sign up |
| Linkedin Employees | 347 | Sign up | Sign up | Sign up |
About Arcutis Biotherapeutics
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
| Price | $9.79 |
| Target Price | Sign up |
| Volume | 2,110,000 |
| Market Cap | $1.14B |
| Year Range | $5.7 - $12.53 |
| Dividend Yield | 0% |
| Analyst Rating | 83% buy |
| Industry | Biotechnology |
In the news
 |
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Stake Boosted by Millennium Management LLCOctober 13 - Biztoc.com |
 |
Arcutis Biotherapeutics, Inc (ARQT): A Small-Cap Leader in Skin Disease TreatmentsOctober 12 - Yahoo |
 |
Arcutis Biotherapeutics (NASDAQ:ARQT) Trading Down 3.6% - Here's What HappenedOctober 11 - Biztoc.com |
|
Zoryve Drives Revenue Growth at Arcutis Biotherapeutics, Inc. (ARQT)October 8 - Yahoo |
 |
Hsbc Holdings PLC Sells 492,187 Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)October 7 - Biztoc.com |
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)October 6 - Finnhub |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 31M | 62M | -31M | -52M | -50M | -0.420 |
| Q1 '24 | 50M | 58M | -8.7M | -35M | -27M | -0.320 |
| Q4 '23 | 5.8M | 58M | -52M | -66M | -58M | -0.720 |
| Q3 '23 | 31M | 236M | -205M | -45M | 154M | -0.730 |
| Q2 '23 | 5.2M | 234M | -229M | -71M | 124M | -1.160 |
Insider Transactions View All
| Edwards Larry Todd filed to sell 136,635 shares at $10. October 3 '24 |
| Welgus Howard G. filed to sell 181,944 shares at $9.3. October 3 '24 |
| Topper David Joseph filed to sell 158,374 shares at $9.5. September 25 '24 |
| Welgus Howard G. filed to sell 191,944 shares at $10.8. September 5 '24 |
| Burnett Patrick filed to sell 194,859 shares at $8.3. August 21 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Joshua Gottheimer Democrat |
Oct 15, 23 | Sell | $1K - $15K |
| Joshua Gottheimer Democrat |
May 19, 23 | Buy | $1K - $15K |
Read more about Arcutis Biotherapeutics (ARQT) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Arcutis Biotherapeutics?
The Market Cap of Arcutis Biotherapeutics is $1.14B.
What is the current stock price of Arcutis Biotherapeutics?
Currently, the price of one share of Arcutis Biotherapeutics stock is $9.79.
How can I analyze the ARQT stock price chart for investment decisions?
The ARQT stock price chart above provides a comprehensive visual representation of Arcutis Biotherapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Arcutis Biotherapeutics shares. Our platform offers an up-to-date ARQT stock price chart, along with technical data analysis and alternative data insights.
Does ARQT offer dividends to its shareholders?
As of our latest update, Arcutis Biotherapeutics (ARQT) does not offer dividends to its shareholders. Investors interested in Arcutis Biotherapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Arcutis Biotherapeutics?
Some of the similar stocks of Arcutis Biotherapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.